Page:United States Statutes at Large Volume 112 Part 4.djvu/712

 112 STAT. 2681-683 PUBLIC LAW 105-277—OCT. 21, 1998 (iv) reduction of drug-related emergency room incidents in the United States (as measured by data of the Drug Abuse Warning Network on ilhcit drug abuse), including incidents involving gunshot wounds and automobile accidents in which illicit drugs are identified in the bloodstream of the victim, by 50 percent by December 31, 2003. (5) FURTHER REDUCTIONS IN DRUG USE, AVAILABILITY, AND CRIME. —Following the submission of a National Drug Control Strategy under this section to achieve the specific targets described in paragraph (4), the Director may formulate a strategy for additional reductions in drug use and availability and drug-related crime beyond the 5-year period covered by the National Drug Control Strategy that has been submitted, (b) ANNUAL STRATEGY REPORT.— (1) IN GENERAL.— Not later than February 1, 1999, and on February 1 of each year thereafter, the President shall submit to Congress a report on the progress in implementing the Strategy under subsection (a), which shall include— (A) an assessment of the Federal effectiveness in achieving the National Drug Control Strategy goals and objectives using the performance measurement system described in subsection (c), including— (i) an assessment of drug use and availability in the United States; and (ii) an estimate of the effectiveness of interdiction, treatment, prevention, law enforcement, and international programs under the National Drug Control Strategy in effect during the preceding year, or in effect as of the date on which the report is submitted; (B) any modifications of the National Drug Control Strategy or the performance measurement system described in subsection (c); (C) an assessment of the manner in which the budget proposal submitted under section 704(c) is intended to implement the National Drug Control Strategy and whether the funding levels contained in such proposal are sufficient to implement such Strategy; (D) measurable data evaluating the success or failure in achieving the annual measurable objectives described in subsection (a)(2)(A)(ii); (E) an assessment of current drug use (including inhalants) and availability, impact of drug use, and treatment availability, which assessment shall include— (i) estimates of drug prevalence and frequency of use as measured by national. State, and local surveys of illicit drug use and by other special studies of— (I) casual and chronic drug use; (II) high-risk populations, including school dropouts, the homeless and transient, arrestees, parolees, probationers, and juvenile delinquents; and (III) drug use in the workplace and the productivity lost by such use; (ii) an assessment of the reduction of drug availability against an ascertained baseline, as measured by-

�